Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging Zoonoses and Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, United States.
World J Gastroenterol. 2011 Nov 14;17(42):4682-8. doi: 10.3748/wjg.v17.i42.4682.
To evaluate the accuracy of two non-invasive tests in a population of Alaska Native persons. High rates of Helicobacter pylori (H. pylori) infection, H. pylori treatment failure, and gastric cancer in this population necessitate documentation of infection status at multiple time points over a patient's life.
In 280 patients undergoing endoscopy, H. pylori was diagnosed by culture, histology, rapid urease test, (13)C urea breath test (UBT), and immunoglobulin G antibodies to H. pylori in serum. The performances of (13)C-UBT and antibody test were compared to a gold standard defined by a positive H. pylori test by culture or, in case of a negative culture result, by positive histology and a positive rapid urease test.
The sensitivity and specificity of the (13)C-UBT were 93% and 88%, respectively, relative to the gold standard. The antibody test had an equivalent sensitivity of 93% with a reduced specificity of 68%. The false positive results for the antibody test were associated with previous treatment for an H. pylori infection [relative risk (RR) = 2.8]. High levels of antibodies to H. pylori were associated with chronic gastritis and male gender, while high scores in the (13)C-UBT test were associated with older age and with the H. pylori bacteria load on histological examination (RR = 4.4).
The (13)C-UBT outperformed the antibody test for H. pylori and could be used when a non-invasive test is clinically necessary to document treatment outcome or when monitoring for reinfection.
评估两种非侵入性检测方法在阿拉斯加原住民人群中的准确性。由于该人群中幽门螺杆菌(H. pylori)感染率、H. pylori 治疗失败率和胃癌率均较高,因此需要在患者的一生中多次记录其感染状态。
在 280 例行内镜检查的患者中,通过培养、组织学、快速尿素酶试验、(13)C 尿素呼气试验(UBT)和血清中 H. pylori 免疫球蛋白 G 抗体来诊断 H. pylori。将(13)C-UBT 和抗体检测的性能与培养阳性或培养阴性但组织学和快速尿素酶试验阳性的金标准进行比较。
(13)C-UBT 的敏感性和特异性分别为 93%和 88%,与金标准相对应。抗体检测的敏感性为 93%,特异性降低至 68%。抗体检测的假阳性结果与 H. pylori 感染的既往治疗有关(相对风险 [RR] = 2.8)。高滴度的 H. pylori 抗体与慢性胃炎和男性有关,而(13)C-UBT 试验的高得分与年龄较大和组织学检查中 H. pylori 细菌负荷有关(RR = 4.4)。
(13)C-UBT 优于 H. pylori 抗体检测,当临床上需要非侵入性检测来记录治疗结果或监测再感染时,可以使用(13)C-UBT。